Experts are increasingly investigating retatrutide, a innovative treatment created by Eli Lilly, as a potential breakthrough in body loss . Different than many previous approaches, retatrutide is a twin-action compound targeting equally GLP-1 and GIP, chemicals that impact appetite and glucose bala